MX9306295A - PHARMACEUTICAL COMPOSITIONS TO TREAT SYMPTOMS OF COLD. - Google Patents

PHARMACEUTICAL COMPOSITIONS TO TREAT SYMPTOMS OF COLD.

Info

Publication number
MX9306295A
MX9306295A MX9306295A MX9306295A MX9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A
Authority
MX
Mexico
Prior art keywords
cold
pharmaceutical compositions
treat symptoms
symptoms
treat
Prior art date
Application number
MX9306295A
Other languages
Spanish (es)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9306295A publication Critical patent/MX9306295A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composición farmacéutica para tratar síntomas de resfriado caracterizada porque comprende un compuesto activo y 3-1-mentoxipropano-1,2-diol.A pharmaceutical composition for treating cold symptoms characterized in that it comprises an active compound and 3-1-mentoxypropane-1,2-diol.

MX9306295A 1992-10-09 1993-10-08 PHARMACEUTICAL COMPOSITIONS TO TREAT SYMPTOMS OF COLD. MX9306295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95501392A 1992-10-09 1992-10-09

Publications (1)

Publication Number Publication Date
MX9306295A true MX9306295A (en) 1994-04-29

Family

ID=25496254

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306295A MX9306295A (en) 1992-10-09 1993-10-08 PHARMACEUTICAL COMPOSITIONS TO TREAT SYMPTOMS OF COLD.

Country Status (7)

Country Link
EP (1) EP0662840A1 (en)
JP (1) JPH08502288A (en)
AU (1) AU678561B2 (en)
CA (1) CA2146637C (en)
MX (1) MX9306295A (en)
NZ (1) NZ256346A (en)
WO (1) WO1994008551A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025003A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Nasal aromatic releasing compositions
AU1716995A (en) * 1994-03-18 1995-10-09 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
CA2277911C (en) * 1997-01-13 2010-09-14 Emory University Compounds and their combinations for the treatment of influenza infection
GB9707977D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Centre filled confectionery
GB9707978D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Throat soothing compositions
DE19814256A1 (en) * 1998-03-31 1999-10-07 Asta Medica Ag Solid, fast-breaking cetirizine formulations
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
KR20040045429A (en) * 2001-09-04 2004-06-01 베링거 인겔하임 인터내셔날 게엠베하 Anti-influenza drugs
DE60319685T2 (en) 2002-04-04 2009-03-26 Pfizer Products Inc., Groton WELCOME COFFEE BAG
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2006034495A2 (en) * 2004-09-23 2006-03-30 Matias Jonathan R Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
AU2016219620B2 (en) * 2006-04-21 2017-05-11 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US9023888B2 (en) 2011-02-02 2015-05-05 Max Reynolds Composition of monoterpenoids having bactericidal properties
JP6539274B2 (en) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド Extruded immediate release abuse deterrent pills
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (en) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド Immediate release abuse deterrent liquid filler form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
CN112972439A (en) * 2019-12-16 2021-06-18 南京亿华药业有限公司 Yumei effervescent tablet and preparation method thereof
CA3169982A1 (en) 2020-02-03 2021-08-12 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
JPS5888334A (en) * 1981-11-20 1983-05-26 Takasago Corp 3-l-menthoxypropane-1,2-diol
JPH06506682A (en) * 1991-04-04 1994-07-28 ザ、プロクター、エンド、ギャンブル、カンパニー Oral pharmaceutical composition for treating upper gastrointestinal tract symptoms

Also Published As

Publication number Publication date
AU678561B2 (en) 1997-06-05
EP0662840A1 (en) 1995-07-19
CA2146637C (en) 2001-02-13
WO1994008551A2 (en) 1994-04-28
JPH08502288A (en) 1996-03-12
NZ256346A (en) 1997-04-24
WO1994008551A3 (en) 1994-06-23
AU4930793A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
MX9306295A (en) PHARMACEUTICAL COMPOSITIONS TO TREAT SYMPTOMS OF COLD.
ES2196160T3 (en) USE OF A COMBINATION OF TENSIOACTIVE, CHELLING AGENTS AND ESSENTIAL OILS FOR EFFECTIVE DISINFECTION.
NO973900L (en) Nitric oxide synthase inhibitor
TR200102647T2 (en) Compositions for improving fertility
ATE370730T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING CHELATING/SEQUESTING AGENTS AND THEIR DERMATOLOGICAL USE
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ATE218868T1 (en) ANTICOUGH COMPOSITIONS CONTAINING THEOBROMINES
PT752813E (en) METABOAL PARASITE PROTEASE INHIBITORS
MX9505181A (en) Utilization of p substance antagonist in a pharmaceutical composition to treat neurogenic skin disorders.
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
ECSP930933A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT
BR9810981A (en) Yohimbine and arginine-containing medication to treat erectile dysfunction
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
ES2146249T3 (en) PHARMACEUTICAL COMPOSITION TO TREAT THE IMPOTENCE CONTAINED BY AN ALPHA-1 INHIBITOR AND AN ALPHA-2 INHIBITOR.
ES2193185T3 (en) PHARMACEUTICAL FORMULATION FOR THE PREVENTION OR PRIOR TREATMENT OF AN INTOXICATION WITH INHIBITORS OF THE ORGANOPHOSPHORATED CHOLINESTERASE.
PT1054681E (en) USE OF COMBINATIONS OF ACTIVE AGENTS CONSISTING OF ANTIBIOTICS AND VEGETABLE EXTRACTS CONTAINING TERPHENE IN VETERINARY MEDICINE
DE69424679D1 (en) COMPOSITION FOR TREATING OR PREVENTING HERPES
ATE200026T1 (en) TREATMENT OF LAMINITIS
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
IT1290910B1 (en) 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, ACTIVE
DE69114922T2 (en) Polysulfide compounds and lipid peroxidation inhibitors that contain these polysulfide compounds as active ingredients.
BR9608721A (en) Pharmaceutical composition and process for treating inflammation
UY24181A1 (en) METHOD TO TREAT AN ACUTE MYOCARDIAL INFARCTION WITH HIRUDIN AND ACETYLSALICYLIC ACID IN PATIENTS NOT UNDER THROMBOLYTIC TREATMENT
UY26735A1 (en) METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS
AR012019A1 (en) CRYPTOFICINE COMPOUND AND ITS USE TO PREPARE A MEDICATION

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees